Login / Signup

Influence of Neoadjuvant Immunotherapy-Chemotherapy on Perioperative Outcomes in Locally Advanced Esophageal Adenocarcinoma.

Yehonatan NevoJames TankelHedi ZhaoJaime RamirezJonathan Cools-LartigueCarmen MullerThierry AlcindorLorenzo Ferri
Published in: Annals of surgical oncology (2024)
The addition of immunotherapy to neoadjuvant chemotherapy for locally advanced esophageal adenocarcinoma does not appear to alter perioperative short-term outcomes significantly after esophagectomy.
Keyphrases